miR-200c Regulation of Metastases in Ovarian Cancer: Potential Role in Epithelial and Mesenchymal Transition. 2016

Siti A Sulaiman, and Nurul-Syakima Ab Mutalib, and Rahman Jamal
UKM Medical Molecular Biology Institute, UKM Medical Centre, Universiti Kebangsaan Malaysia Kuala Lumpur, Malaysia.

Among the gynecological malignancies, ovarian cancer is the most fatal due to its high mortality rate. Most of the identified cases are epithelial ovarian cancer (EOC) with five distinct subtypes: high-grade serous carcinoma, low-grade serous carcinoma, mucinous carcinoma, endometrioid carcinoma, and clear-cell carcinoma. Lack of an early diagnostic approach, high incidence of tumor relapse and the heterogenous characteristics between each EOC subtypes contribute to the difficulties in developing precise intervention and therapy for the patients. MicroRNAs (miRNAs) are single-stranded RNAs that have been shown to function as tumor suppressors or oncomiRs. The miR-200 family, especially miR-200c, has been shown to be implicated in the metastasis and invasion of ovarian carcinoma due to its functional regulation of epithelial-to-mesenchymal transition (EMT). This mini review is aimed to summarize the recent findings of the miR-200c functional role as well as its validated targets in the metastasis cascade of ovarian cancer, with a focus on EMT regulation. The potential of this miRNA in early diagnosis and its dual expression status are also discussed.

UI MeSH Term Description Entries

Related Publications

Siti A Sulaiman, and Nurul-Syakima Ab Mutalib, and Rahman Jamal
August 2025, Journal of visualized experiments : JoVE,
Siti A Sulaiman, and Nurul-Syakima Ab Mutalib, and Rahman Jamal
January 2020, Cancer management and research,
Siti A Sulaiman, and Nurul-Syakima Ab Mutalib, and Rahman Jamal
January 2015, Biological & pharmaceutical bulletin,
Siti A Sulaiman, and Nurul-Syakima Ab Mutalib, and Rahman Jamal
April 2014, International journal of molecular medicine,
Siti A Sulaiman, and Nurul-Syakima Ab Mutalib, and Rahman Jamal
March 2020, Gene,
Siti A Sulaiman, and Nurul-Syakima Ab Mutalib, and Rahman Jamal
July 2017, BMC cancer,
Siti A Sulaiman, and Nurul-Syakima Ab Mutalib, and Rahman Jamal
January 2017, International journal of ophthalmology,
Siti A Sulaiman, and Nurul-Syakima Ab Mutalib, and Rahman Jamal
May 2010, Cancer letters,
Siti A Sulaiman, and Nurul-Syakima Ab Mutalib, and Rahman Jamal
March 2014, Oncogene,
Copied contents to your clipboard!